ClinicalTrials.gg
DrugRead study by study

Mazdutide clinical trials

Also written IBI362 and LY3305677.

studies test it
44
open now
20
in phase 3
10
first study started
2016
ClinicalTrials.gov finds 45 studies for mazdutide. How that becomes 44 here

Every study that search finds has been read, to see whether and how it gives mazdutide. ClinicalTrials.gov counts as of Nov 15, 2026. How drug pages count

  1. 45Found by its intervention search · See all 45 hereIt also reads titles, arm labels, keywords and descriptions, and counts the drug’s other names. Of these, 21 name it in an intervention entry. The counts it shows beside each synonym overlap: a study writing two names counts under both.
  2. +1Give it under a name that search misses: a biosimilar’s code or a misspelling
  3. 46Give mazdutide to participants
  4. −2Compare another treatment with it
  5. 44Test it: the count on this site

Get an email when these change. Save the mazdutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Mazdutide
14
Mazdutide(Dual GLP-1R/GCGR Agonist)
2

Development codes

IBI362
22
LY3305677
7

Studies by the year they started

43 studies that test it; most in 2026 (14); 1 more planned to start later

Studies that test mazdutide, by start year
YearStudies
20161
20171
20191
20202
20213
20222
20237
20243
20259
202614

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
12
Phase 3
10
Phase 4
5
No phase
9

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 27 · Other 17

Innovent Biologics (Suzhou) Co. Ltd. (20) · Eli Lilly and Company (7) · Shanghai Zhongshan Hospital (2) · Tongji Hospital (2) · Peking University People's Hospital (1) · Beijing Anzhen Hospital (1) · Hongwei Jiang (1) · The Second Affiliated Hospital of Chongqing Medical University (1)

Often tested with

Tested in the same studies.

Dulaglutide (1) · Atorvastatin (1) · Finerenone (1) · Eloralintide (1) · Naperiglipron (1) · Macupatide (1) · Semaglutide (1) · Tirzepatide (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Mazdutide is the comparator. A study of two new drugs counts under both.

  • 1HDM1005 · Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. · next primary completion Aug 2027
Reaching primary completion within a year · 5, 3 in phase 3

Studies that test mazdutide, phase 3 first.

Studies

Open first, then newest update. How each study uses mazdutide has had a first review, but it may not be perfect: check the study record before relying on it for anything important, and report a problem from its row. Some give it without naming it in an intervention entry: those were found by reading the record.

Testing it · 44

See all 44 studies that test mazdutide →

Tested on its own · 35 — no other medicine in its arm

Showing 20 of 35. See all 35 →

Tested with established drugs · 3 — they are given beside it
Tested in a combination · 6 — another drug in the study is under test too
As the comparator · 2 — what is tested is compared with mazdutide

What changed recently

From the registry's own updates since Oct 17, 2026.

Codes

What other systems call mazdutide · ClinicalTrials.gg INT001730

  • MeSH (NLM) C000719829mazdutideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) MB76Z4IBZ5MAZDUTIDEConfirmed FDA, NLM, Wikidata
  • Wikidata Q123248554mazdutideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C186406MazdutideOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.

Start the discussion